Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate if there is any clinical difference in patients 3.5-12kg who undergo cardiac surgery with cardiopulmonary bypass that do and do not receive blood products as part of their procedure. The main hypothesis of the study is that the patients undergoing bloodless cardiac surgery will have decreased morbidity and mortality when compared to the cohort that did receive blood as well as a shorter ICU and hospital length of stay.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Blood prime for cardiopulmonary bypass | Active Comparator |
| |
| clear prime for cardiopulmonary bypass | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| blood use for priming cardiopulmonary bypass circuit | Other | one arm will have the cardiopulmonary bypass circuit primed with blood |
|
| Measure | Description | Time Frame |
|---|---|---|
| Age of patients undergoing bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | age in months | 30 days |
| Weight of patients undergoing bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | weight in kg | 30 days |
| Gender of patients undergoing bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | sex | 30 days |
| Demographics of bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | race | 30 days |
| Diagnosis of patients undergoing bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | preoperative diagnosis | 30 days |
| Surgery performed in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | surgery performed | 30 days |
| Previous surgery prior to bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | any previous surgery | 30 days |
| Blood received during bloodless cardiac surgery in patients 3.5-12kg (categorical variable) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Children's Hospital of Georgia | Recruiting | Augusta | Georgia | 30912 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006330 | Heart Defects, Congenital |
| ID | Term |
|---|---|
| D018376 | Cardiovascular Abnormalities |
| D002318 | Cardiovascular Diseases |
| D006331 | Heart Diseases |
| D000013 | Congenital Abnormalities |
Not provided
Not provided
| ID | Term |
|---|---|
| D002315 | Cardiopulmonary Bypass |
| ID | Term |
|---|---|
| D005112 | Extracorporeal Circulation |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| clear prime for cardiopulmonary bypass | Other | this arm will not have bypass circuit primed with blood |
|
blood product received
| 30 days |
| Volume transfused during bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | volume of blood transfusion in mL | 30 days |
| Number of patients with unplanned reoperation in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | unplanned reoperation | 30 days |
| Number of patients with unplanned cardiac catheterization in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | unplanned cardiac catheterization | 30 days |
| Number of patients with a neurologic complication in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | neurologic complication | 30 days |
| Number of patients with chylothorax in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | chylothorax | 30 days |
| Number of patients with vocal cord injury in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | vocal cord injury | 30 days |
| Number of patients with diaphragm paralysis in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | diaphragm paralysis | 30 days |
| Number of patients with pacemaker implantation in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | pacemaker implantation | 30 days |
| Number of patients with postoperative pneumothorax in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | postoperative pneumothorax | 30 days |
| Number of patients with wound infection in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | wound infection | 30 days |
| Number of patients with bleeding requiring reoperation in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | bleeding requiring reoperation | 30 days |
| Number of patients with pericardial effusion in bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | pericardial effusion | 30 days |
| Number of patients who died following bloodless cardiac surgery in patients 3.5-12kg (categorical variable) | mortality | 30 days |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |